Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Jul 18;6(9):10.1158/1940-6207.CAPR-13-0050. doi: 10.1158/1940-6207.CAPR-13-0050

Table 3.

Dietary biomarkers comparing intervention to control at baseline and 6-month follow-up in the Dietary Intervention in Bladder Cancer Study (DIBS).

Baseline 6-month Follow-up p-valuec
Control Mean (SE) Intervention Mean (SE) Control Mean (SE) Intervention Mean (SE)

N = 18 N = 30 N = 15 N = 24

Lutein plus zeaxanthin (umol/L) a 0.38 (0.04) 0.33 (0.07) 0.37 (0.03) 0.32 (0.05) 0.97
Cryptoxanthin (umol/L) a 0.19 (0.04) 0.19 (0.06)* 0.18 (0.04) 0.13 (0.03)* 0.42
Lycopene (umol/L) a 0.78 (0.06) 0.65 (0.06) 0.76 (0.11) 0.68 (0.08) 0.38
Alpha-carotene (umol/L) a 0.20 (0.03) 0.14 (0.04)** 0.17 (0.03) 0.16 (0.03)** 0.03
Beta-carotene (umol/L) a 0.62 (0.09) 0.47 (0.09) 0.69 (0.16) 0.55 (0.08) 0.40
Total carotenoids (umol/L) a 2.2 (0.18) 1.70 (0.19) 2.2 (0.29) 1.80 (0.20) 0.60
Isothiocyanate (umol/L) b 95.5 (42.9) 40.0 (14.4) 56.9 (23.0) 59.9 (14.8) 0.32
a

Plasma

b

Urine

c

p-value based on Wilcoxon rank sum test comparing changes in each marker between groups.

between group difference at baseline Wilcoxon test p-value < 0.1

between group difference at baseline Wilcoxon test p-value < 0.05

*

within group change p-value < 0.1

**

within group change p-value < 0.05